Document:

Exhibit 10.1

 

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement
(this “Agreement”) is entered into as of the 20th day of June, 2016, by and between DGSE Companies,
Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”), Elemetal,
LLC, a limited liability company organized and existing under the laws of the State of Delaware (“Elemetal”),
and NTR Metals, LLC, a limited liability company organized and existing under the laws of the State of Texas (“NTR”,
and together with Elemetal, the “Purchasers”).

 

WHEREAS, the Company desires
to sell to the Purchasers, and the Purchasers desire to purchase from the Company, shares of the Company’s common stock,
par value $.01 per share (the “Common Stock”), on the terms and subject to the conditions set forth in this
Agreement; and

 

WHEREAS, the Company desires
to issue to Elemetal, and Elemetal desires to receive from the Company, a warrant to purchase additional shares of Common Stock,
on the terms and subject to the conditions set forth in this Agreement and the Warrant (as defined herein).

 

NOW, THEREFORE, in consideration
of the premises and the representations, warranties, covenants and agreements contained in this Agreement, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the parties
hereby agree as follows:

 

Article 1

Purchase and Sale

 

1.1         Purchase
and Sale Transaction.

 

(a)          Subject
to the terms and conditions of this Agreement, the Company hereby agrees to issue and sell to Elemetal, and Elemetal hereby agrees
to purchase from the Company: (i) an aggregate of 8,536,585 shares of Common Stock (the “Elemetal Shares”) at
a purchase price of U.S.$0.41 per share, which Elemetal Shares shall be sold and issued to, and purchased by, Elemetal at the Closing;
and (ii) a warrant (the “Warrant”), substantially in the form attached hereto as Exhibit A, to purchase
an additional 1,000,000 shares of Common Stock (the “Warrant Shares”) at an exercise price of U.S. $0.65 per
Warrant Share. The purchase price for the Elemetal Shares and the Warrant shall be payable by the cancellation and forgiveness
of $3,500,000 of the total debt owed by the Company to Elemetal (the “Elemetal Indebtedness”) as a result of
bullion-related transactions (the “Elemetal Consideration”).

 

(b)          Subject
to the terms and conditions of this Agreement, the Company hereby agrees to issue and sell to NTR, and NTR hereby agrees to purchase
from the Company such number of whole shares of Common Stock (the “NTR Shares”) equal to the NTR Indebtedness
(as defined below) divided by the purchase price of U.S. $0.41 per share, which NTR Shares shall be sold and issued to, and purchased
by, NTR at the Closing. The purchase price for the NTR Shares shall be payable by the cancellation and forgiveness of the debt
owed by the Company to NTR as of the Closing (the “NTR Indebtedness”) as a result of that certain Loan Agreement
between the Company and NTR dated July 19, 2012 and an associated $7,500,000 Revolving Credit Note of the same date executed by
the Company in favor of NTR (the “NTR Consideration”, and together with the Elemetal Consideration, the “Aggregate
Consideration”). No fractional shares shall be issued.

 

     

     

    

 

(c)          The
parties hereto agree that (i) upon the issuance and delivery by the Company of the Elemetal Shares and the Warrant, the Elemetal
Indebtedness shall be fully satisfied, and (ii) upon the issuance and delivery by the Company of the NTR Shares, the NTR Indebtedness
shall be fully satisfied.

 

(d)          The
purchase and sale transactions contemplated in Section 1.1(a) and Section 1.1(b), the satisfaction of the Elemetal
Indebtedness and the NTR Indebtedness contemplated in Section 1.1(c), together with all other transactions contemplated
by this Agreement, are sometimes hereinafter referred to, collectively, as the “Transactions.” The Elemetal
Shares and the NTR Shares are sometimes hereinafter referred to, collectively, as the “Securities” and, individually,
as a “Security.”

 

1.2         Closing.

 

(a)          The
consummation of the sale and issuance to, and purchase by, the Purchasers of the Securities and of the delivery to Elemetal of
the Warrant (the “Closing”) shall take place at such time as shall be fixed by mutual agreement of the Company
and the Purchasers as promptly as practicable after the satisfaction or waiver of all of the conditions precedent set forth under
Article 5. At the Closing, (i) Elemetal shall deliver to the Company evidence of the Elemetal Consideration in form and
substance acceptable to the Company, (ii) the Company shall deliver to Elemetal (A) a stock certificate (or evidence of book-entry
issuance) representing the Elemetal Shares and (B) the Warrant, (iii) NTR shall deliver to the Company evidence of the NTR Consideration
in form and substance acceptable to the Company and (iv) the Company shall deliver to NTR a stock certificate (or evidence of book-entry
issuance) representing the NTR Shares.

 

(b)          The
Closing shall be held at the offices of the Company, at 15850 Dallas Parkway, Suite 140, Dallas, Texas, 75248.

 

Article 2

Representations and Warranties of the Company

 

The Company represents
and warrants to the Purchasers as follows:

 

2.1         Organization;
Good Standing; Qualification and Power.  The Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Nevada, has all requisite power and authority to own, lease and operate its assets and to carry
on its business as presently being conducted, and is qualified to do business and is in good standing in every jurisdiction in
which the failure so to qualify or be in good standing could reasonably be expected to have a Material Adverse Effect (as defined
below) on the Company

 

    	 	2	 

     

    

 

2.2         Authorization.
The Company has all requisite power and authority to execute and deliver this Agreement, the Securities, the Warrant and the Warrant
Shares and any and all instruments necessary or appropriate in order to effectuate fully the terms thereof and all related transactions
and to perform its obligations thereunder. The execution and delivery by the Company of this Agreement have been duly authorized
by all requisite corporate action of the Company. Except for the Required Shareholder Approval and the authorizations, consents,
waivers and approvals to be obtained at or prior to the Closing, the performance by the Company of its obligations hereunder and
the issuance, sale and delivery of the Securities, the Warrant and the Warrant Shares have been duly authorized by all requisite
corporate action of the Company.

 

2.3         No
Conflict. Neither the execution and delivery by the Company of this Agreement, the performance by the Company of its obligations
hereunder nor the issuance, sale and delivery of the Securities and the Warrant will result in any violation of, be in conflict
with, result in the acceleration of, create in any party the right to accelerate, terminate, modify or cancel or constitute a default
under or result in the imposition of any lien under, with or without the passage of time or the giving of notice: (a) any provision
of the Company’s Articles of Incorporation, as amended, restated or modified (the “Articles of Incorporation”)
or Bylaws, as amended, restated or modified (the “Bylaws”); (b) any provision of any judgment, decree or order
to which the Company is a party or by which it is bound; (c) any material contract or agreement to which the Company is a party
or by which it is bound; or (d) assuming receipt of the Required Shareholder Approval (as defined herein), any statute, rule or
governmental regulation applicable to the Company or its assets; except, in the case of each of the foregoing, where such violation,
conflict, termination, lien, cancellation, modification or default would not have a Material Adverse Effect (as hereinafter defined)
and except, in the case of each of the foregoing, provisions, contracts, agreements, statutes, rules or governmental regulations
as to which authorizations, consents, amendments, waivers and approvals will have been obtained or effected at or prior to the
Closing. Other than state blue sky securities filings, the filing of a Form D with the Securities and Exchange Commission (the
“SEC”), any securities filings with foreign governments or agencies or any consents that have been obtained,
the Company has not been or is not required to give any notice to, make any filing with, or obtain any authorization, consent or
approval of any governmental entity for the execution and delivery of this Agreement, the Securities or the Warrant. As used herein,
the term “Material Adverse Effect” shall mean any effect, change, event, state of fact, development, circumstance
or condition (including changes in laws, rules or regulations applicable to the Company and its business) which, when considered
individually or in the aggregate with all other effects, changes, events, state of facts, developments, circumstances and conditions,
has materially and adversely affected, or could reasonably be expected to materially and adversely affect, the results of operations,
financial condition, assets, liabilities, or business of the Company and its subsidiaries taken as a whole; provided, however,
that a “Material Adverse Effect” shall not be deemed to include (i) any changes resulting from general economic or
political conditions, (ii) circumstances that affect the precious metals industry and/or the retail jewelry industry generally
or (iii) force majeure events, acts of terrorism or acts of war.

 

2.4         Valid
Issuance of Securities and the Warrant Shares.

 

(a)          When
issued, sold and delivered in accordance with this Agreement to the Purchasers upon the Purchasers’ delivery of the Aggregate
Consideration to the Company therefor as provided hereby, the Securities and the Warrant will have been duly authorized, validly
issued, fully paid and nonassessable with no personal liability attaching to the ownership thereof and will be free and clear of
all liens, charges and encumbrances of any nature whatsoever except for restrictions on transfer under this Agreement and under
applicable federal and state securities laws.

 

    	 	3	 

     

    

 

(b)          Upon
the Purchasers’ delivery of the exercise price for the Warrant Shares (as set forth in the Warrant), the Warrant Shares will
have been duly authorized and will be validly issued, and the Warrant Shares will be fully paid and nonassessable with no personal
liability attaching to the ownership thereof and will be free and clear of all liens, charges and encumbrances of any nature whatsoever
except for restrictions on transfer under this Agreement and under applicable federal and state securities laws

 

2.5         Validity.
This Agreement has been duly executed and delivered by the Company.

 

2.6         Compliance
with Laws; Organizational Documents. The Company (a) has complied in all material respects with, and is in material compliance
with, all laws applicable to it and its business, and (b) has all permits necessary for the conduct of its business as presently
conducted, other than such permits that, if not obtained, could not reasonably be expected to have a Material Adverse Effect on
the Company. Such permits are in full force and effect, the Company has not received notice of any material violations with respect
to any thereof, and no material proceeding is pending or threatened to revoke or limit any thereof.

 

2.7         Capitalization
of the Company.

 

(a) Immediately prior to
the Closing, (i) the authorized capital stock of the Company consisted of the classes and amounts set forth on Schedule A
hereto, and (ii) the issued and outstanding capital stock of the Company (separated by class and series) was as set forth on Schedule
B hereto.

 

(b) Except as set forth
in the Company’s filings with the SEC or as set forth on Schedule C hereto, there are no (i) outstanding warrants,
options, rights, agreements, convertible securities or other commitments or instruments pursuant to which the Company is or may
become obligated to issue or sell any shares of its capital stock or other securities or (ii) preemptive or similar rights to purchase
or otherwise acquire shares of the capital stock or other securities of the Company pursuant to any provision of law, the Company’s
Articles of Incorporation or Bylaws or any contract to which the Company, or to the Company’s Knowledge, any stockholder
(other than Purchasers or their Affiliates) thereof, is a party. As used herein, the Company’s “Knowledge” means
the actual knowledge of Matthew Peakes or Nabil Lopez.

 

2.8         Intellectual
Property. There is no pending or, to the Company’s Knowledge, threatened claim or litigation against the Company asserting
that the Company infringes upon or otherwise violates any intellectual property right of any person. No Proceedings in which the
Company alleges that any person is infringing upon, or otherwise violating, any intellectual property right owned by the Company
are pending, and none have been served by, instituted or asserted by the Company, nor, to the Company’s Knowledge, are any
proceedings threatened alleging any such violation or infringement.

 

    	 	4	 

     

    

 

 

2.9         Material
Agreements. (a) There is no material breach or default by the Company or, to the Company’s Knowledge, any other party
under any contract to which the Company or any of its subsidiaries is a party that is material to the Company’s business,
operations, assets, financial condition or operating results (each, a “Material Agreement”) and (b) each Material
Agreement is in full force and effect, constitutes the valid and binding obligation of the Company, and, to its Knowledge, the
respective other parties thereto (assuming due execution by the parties other than the Company or its subsidiaries, as applicable),
and is enforceable in accordance with its terms, except as enforceability thereof may be limited by applicable bankruptcy, reorganization,
insolvency or other laws affecting creditors’ rights generally or by general principles of equity.

 

2.10       Brokers
and Finders. On behalf of the Company, there is no agent, broker, investment banker, consultant, Person or firm that has acted
on behalf, or under the authority of, the Company or, to the Company’s Knowledge, any of its stockholders (other than Purchasers
or their Affiliates), or will be entitled to any fee or commission directly or indirectly from the Company or, to the Company’s
Knowledge, any of its stockholders (other than Purchasers or their Affiliates), in connection with the Transactions.

 

2.11       Financial
Statements. The Company has filed with the SEC its audited balance sheet as of December 31, 2015 (the “Statement Date”),
and the audited statements of income and cash flows for the year ending on the Statement Date (together, the “Audited
Financial Statements”), and its unaudited balance sheet as of March 31, 2016, and the unaudited statements of income
and cash flows for the quarter ended March 31, 2016 (together, the “Unaudited Financial Statements”). The
Audited Financial Statements and the Unaudited Financial Statements, together with the notes thereto, have been prepared in accordance
with generally accepted accounting principles in the United States, consistently applied throughout the periods indicated, subject
in the case of the Unaudited Financial Statements, to normal year-end adjustments, and present fairly in all material respects
the financial condition and position and results of operation of the Company as of the Statement Date or March 31, 2016, as applicable,
and for the periods indicated.

 

2.12       No
Consent or Approval Required. Other than the Required Shareholder Approval, no consent, approval or authorization of, or declaration
to or filing with, any person is required by the Company for the valid authorization, execution and delivery by the Company of
this Agreement, the Securities or the Warrant or for the consummation of the Transactions, other than (a) those consents, approvals,
authorizations, declarations or filings that have been obtained or made, as the case may be, and (b) filings pursuant to federal
or state securities and any other applicable laws (all of which filings have been made by the Company, other than those which are
required to be made after the Closing, and which will be duly made in accordance with time periods under applicable laws) in connection
with the sale of the Securities and the Warrants.

 

2.13       Changes.
Except as set forth in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 or in Current Reports
on Form 8-K filed since March 31, 2016, or as set forth on Schedule D hereto, since March 31, 2016, there has not been:

 

(a)          Any
change in or effect on the assets, liabilities, financial condition, prospects or operations of the Company from that reflected
in the Unaudited Financial Statements, other than changes in the ordinary course of business, none of which individually or in
the aggregate has had or could reasonably be expected to have a Material Adverse Effect on the Company;

 

    	 	5	 

     

    

 

(b)          Any
waiver by the Company of a material right of the Company or a material debt owed to the Company;

 

(c)          Any
sale, assignment, license or transfer of ownership of any intellectual property rights, other than in the ordinary course of business;

 

(d)          Any
change in any Material Agreement that has had or could reasonably be expected to have a Material Adverse Effect on the Company;
or

 

(e)          Any
other event or condition of any character that, either individually or cumulatively, has had or could reasonably be expected to
have a Material Adverse Effect on the Company.

 

2.14       Absence
of Undisclosed Liabilities. The Company has no material Liabilities, except (a) to the extent reflected or reserved against
on the balance sheet disclosed in the Unaudited Financial Statements and (b) liabilities arising in the ordinary course of business
consistent with past practice since March 31, 2016. There are no material loss contingencies (as such term is used in Statement
of Financial Accounting Standards No. 5, or any successor thereto, issued by the Financial Accounting Standards Board) of or affecting
the Company that are required to be disclosed or for which adequate provision was required to be made on the balance sheet included
in the Unaudited Financial Statements that have not been disclosed or for which adequate provision has not been made on the balance
sheet included in the Unaudited Financial Statements or in the notes thereto.

 

2.15       Insurance.
The Company maintains adequate insurance covering the risks of the Company, if any, of such types and in such amounts and with
such deductibles as are customary for other companies of a similar size engaged in similar lines of business. All insurance held
by the Company is in full force and effect and is issued by insurers of recognized responsibility.

 

2.16       Title
to Assets, Properties and Rights. The Company has good and marketable title (or a valid leasehold interest or license) to all
of the assets (whether real, personal or mixed) reflected as being owned (or leased or licensed) by the Company on the balance
sheet included in the Unaudited Financial Statements (except for those assets subsequently disposed of in the ordinary course of
business), free and clear of all liens, except for (a) liens for current taxes, assessments and other governmental charges not
yet due and payable and for which adequate reserves have been established on the books of the Company; (b) easements, covenants,
conditions and restrictions (whether or not of record) as to which no material violation or encroachment exists or, if such violation
or encroachment exists, as to which the cure of such violation or encroachment would not materially interfere with the conduct
of the Company’s business as presently conducted; (c) any zoning or other governmentally established restrictions or encumbrances;
(d) worker’s or unemployment compensation liens arising in the ordinary course of business; (e) mechanic’s, materialman’s,
supplier’s, vendor’s or similar liens arising in the ordinary course of business securing amounts that are not delinquent;
(f) those liens that do not, individually or cumulatively, have or could reasonably be expected to have a Material Adverse Effect
on the Company; and (g) liens set forth on Schedule E hereto.

 

    	 	6	 

     

    

 

2.17       Taxes.
The Company has timely filed all material tax returns that are required to be filed, and has paid all Taxes as shown on such returns
and on all assessments received by it to the extent that such taxes have become due, except to the extent the Company is contesting
any such assessment in good faith. All such returns were true and correct in all material respects. Except as described in the
Company’s filings with the SEC, the Company has not received notice of any material tax deficiency proposed or assessed against
it, and has not executed any waiver of any statute of limitations on the assessment or collection of any tax that has not yet expired.
Except as described in the Company’s filings with the SEC, none of the Company’s tax returns is currently being audited
by governmental authorities, and no taxing authority has notified the Company, orally or in writing, that such taxing authority
will or may audit any such return.

 

2.18       Litigation
and Other Proceedings. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company,
whether at law or in equity, whether civil or criminal in nature, that could reasonably be expected to have, either individually
or in the aggregate, a Material Adverse Effect on the Company.

 

2.19       Proxy
Statements. The Proxy Statements (as defined below) will not, on the dates first mailed to stockholders and at the time of
the Company Stockholder Meeting (as defined below), contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they are made, not misleading; provided, that no representation is made as to information in the Proxy Statements that is
provided or supplied by Purchasers or their Affiliates or representatives. The Proxy Statements will comply as to form in all material
respects with the applicable provisions of the Securities Act of 1933 (the “Securities Act”) and the Securities
Exchange Act of 1934.

 

2.20       Board
Recommendation; Required Vote. The Board of Directors of the Company, at a meeting duly called and held, by unanimous vote
of all of the members of the Board of Directors of the Company has (i) in all respects approved the Transactions and the Amendment
(as defined below); (ii) resolved to recommend that the stockholders of the Company approve the Transactions and the Amendment;
and (iii) directed that the approval of the Transactions and Amendment be submitted to stockholders of the Company for consideration
in accordance with this Agreement, which resolutions as of the date of this Agreement, have not been subsequently rescinded, modified
or withdrawn in any way (collectively, the “Board Recommendation”). The Required Shareholder Approval is the
only vote of the holders of capital stock of the Company necessary to approve the Transactions and the Amendment.

 

    	 	7	 

     

    

 

Article 3

Representations and Warranties of the Purchasers

 

The Purchasers severally
and not jointly represent and warrant to the Company as follows:

 

3.1         Authorization.
The execution and delivery by each Purchaser of this Agreement and the performance by each Purchaser of its obligations hereunder
have been duly authorized by all requisite limited liability company action of each Purchaser.

 

3.2         No
Conflict. Neither the execution and delivery by either Purchaser of this Agreement nor the performance by either Purchaser
of its obligations hereunder will result in any violation of, be in conflict with, or constitute a default under, with or without
the passage of time or the giving of notice: (a) any provision of either Purchaser’s governing documents; (b) any provision
of any judgment, decree or order to which either Purchaser is a party or by which it is bound; (c) any material contract or agreement
to which either Purchaser is a party or by which it is bound; or (d) any statute, rule or governmental regulation applicable to
either Purchaser; except, in the case of each of the foregoing, provisions, contracts, agreements, statutes, rules or governmental
regulations as to which authorizations, consents, amendments, waivers and approvals will have been obtained or effected at or prior
to the Closing.

 

3.3         Validity.
This Agreement has been duly executed and delivered by each Purchaser and, assuming due and valid authorization, execution and
delivery hereof by the Company, constitutes the legal, valid and binding obligation of each Purchaser, enforceable against each
Purchaser in accordance with its terms except: (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally; and (b) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies.

 

3.4         Investment
Representations.

 

(a)          Each
Purchaser: (i) is an “accredited investor” within the meaning of Rule 501 of Regulation D promulgated under the Securities
Act, and was not organized for the specific purpose of acquiring the Securities, the Warrant or the Warrant Shares; or (ii) is
not a “U.S. Person” within the meaning of Rule 902 of Regulation S promulgated under the Securities Act.

 

(b)          Each
Purchaser has sufficient investment knowledge and experience so as to be able to evaluate the risks and merits of its investment
in the Company, and each Purchaser is able financially to bear the risks of its investment.

 

(c)          It
is the present intention that the Securities being purchased by each Purchaser are being acquired (and, to the extent the Warrant
is exercised, the Warrant Shares will be acquired) for such Purchaser’s own account for the purpose of investment and not
with a present view to or for sale in connection with any distribution thereof.

 

(d)          Each
Purchaser understands that: (i) none of the Securities, the Warrant or the Warrant Shares have been registered under the Securities
Act by reason of their issuance in a transaction exempt from the registration requirements of the Securities Act pursuant to Section
4(a)(2) thereof or Rule 506 or 903 promulgated under the Securities Act; (ii) the Securities must be held indefinitely (or, in
the case of the Warrant, until the exercise in full or expiration or termination thereof) unless a subsequent disposition thereof
is registered under the Securities Act or is exempt from such registration; (iii) the Warrant and each stock certificate representing
the Elemetal Shares, the NTR Shares, and, to the extent the Warrant is exercised, any stock certificate representing the Warrant
Shares acquired upon such exercise will bear a legend, among others, to the effect of clauses (i) and (ii) above; and (iv) the
Company will make a notation on its transfer books to the effect of clauses (i) and (ii) above.

 

    	 	8	 

     

    

 

(e)          Each
Purchaser acknowledges that the Company has made available to such Purchaser all documents and information that such Purchaser
has requested relating to the Company, the Securities, the Warrant Shares, this Agreement and the Transactions.

 

3.5         Legends.
Each Purchaser understands that the representatives of the Company will make notations in the appropriate records of the Company
of the restrictions on the transferability of the Securities and the Warrant Shares and may stamp or affix to any document or instrument
representing the Securities or Warrant Shares an appropriate legend stating, in effect, that the resale of the Securities or Warrant
Shares has not been registered under the Securities Act and that transfers thereof must be made in accordance with an available
exemption from registration under the Securities Act or in a transaction registered under the Securities Act.

 

3.6         Litigation.
There are no actions, suits or proceedings of any nature pending or, to the knowledge of either Purchaser, threatened against or
by either Purchaser, any Affiliate of either Purchaser, any of its properties or any of their managers, officers or directors (in
their capacities as such) that challenge or seek to prevent, enjoin or otherwise delay the Transactions. To the knowledge of each
Purchaser, no event has occurred or circumstances exist that may give rise to or serve as a basis for any such action, suit or
proceeding. As used herein, “Affiliate” means, as to either Purchaser, any other person that, directly or indirectly
through one or more intermediaries, controls, is controlled by, or is under common control with such Purchaser, whether by contract,
voting power, or otherwise. The word “control” means the right to direct, whether by means of the holding of
shares or the possession of voting power, via contract or otherwise, the affairs of such person, firm, or company. Without limiting
the foregoing, a person is deemed to be an Affiliate of either Purchaser if such Purchaser owns, directly or indirectly, 50% or
of the voting securities of the specified person.

 

3.7         Disclosure
of Certain Information. Each Purchaser understands and acknowledges that the Company may be required to disclose to the SEC
this Agreement and information relating to this Agreement, and hereby agrees that the Company, in its discretion, may disclose
this Agreement and such information to the SEC at such time and in such manner as the Company deems reasonable or necessary.

 

3.8         Brokers
and Finders. On behalf of either Purchaser or its Affiliates (other than the Company and its subsidiaries), there is no agent,
broker, investment banker, consultant, Person or firm that has acted on behalf, or under the authority of, either Purchaser or
its Affiliates or, to such Purchaser’s knowledge, any of its stockholders, or will be entitled to any fee or commission directly
or indirectly from either Purchaser or its Affiliates or, to such Purchaser’s knowledge, any of its stockholders in connection
with the Transactions.

 

3.9         No
Rights as Stockholder. Each Purchaser acknowledges that, except as otherwise provided herein, its purchase obligations under
this Agreement will not entitle such Purchaser to any of the rights, including, without limitation, voting rights, information
rights and rights to receive dividends or distributions, of a stockholder of the Company until the Closing.

 

    	 	9	 

     

    

 

Article 4

Covenants and Agreements

 

4.1         Cooperation;
Commercially Reasonable Efforts. The Company and the Purchasers shall cooperate with each other and use their respective commercially
reasonable efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable
under this Agreement and applicable laws, rules and regulations to consummate and make effective the Transactions and the Amendment
as soon as practicable, including preparing and filing as promptly as practicable all documentation to effect all necessary applications,
notices, proxy statements, filings and other documents and to obtain as promptly as practicable all approvals of the Company’s
stockholders described in Section 5.1(a) and Section 5.1(b) and all approvals, permits, consents and authorizations
necessary or advisable to be obtained from the any third party and/or any governmental entity in order to consummate the Transactions
and to effect the Amendment.

 

4.2         Proxy
Statement; Company Stockholder Meeting.

 

(a)          As
promptly as practicable after the date of this Agreement, the Company shall prepare and file with the SEC a Notice of Meeting and
Preliminary Proxy Statement relating to a meeting of the Company’s stockholders (the “Company Stockholder Meeting”)
to be held for the purpose of voting on the Transactions and other matters as may be deemed necessary or advisable by the Company,
including, without limitation, an amendment of the Company’s Articles of Incorporation to increase the number of authorized
shares of Common Stock (the “Amendment”). As promptly as practicable after filing such Notice of Meeting and
Preliminary Proxy Statement, but in any event subject to the rules and regulations of the SEC, the Company shall prepare and file
with the SEC, and mail to its stockholders of record as of the close of business on the record date established by the Company
for the Company Stockholder Meeting (the “Record Stockholders”), a Notice of Meeting and Definitive Proxy Statement
relating to the Company Stockholder Meeting. The Notice of Meeting and Preliminary Proxy Statement and Notice of Meeting and Definitive
Proxy Statement are sometimes hereinafter referred to as the “Proxy Statements.” A reasonable time prior to
the mailing thereof, the Purchasers shall have the opportunity to review the Proxy Statements and the Company shall review and
consider all reasonable revisions proposed by the Purchasers to the extent reasonably satisfactory to the Purchasers.

 

(b)          The
Purchasers shall furnish all information concerning the Purchasers as the Company may reasonably request in connection with the
preparation of the Proxy Statements, including, without limitation, any information in response to comments received from the SEC,
if applicable.

 

(c)          The
Company Stockholder Meeting shall be called for a date which, after taking into consideration the provisions of the Articles of
Incorporation and Bylaws, the Nevada Corporations Code, the rules and regulations of the SEC and the NYSE MKT and the recommendations
of any proxy solicitor engaged by the Company with respect to the Company Stockholder Meeting and the Transactions, is as prompt
as practicable after the Notice of Meeting and Definitive Proxy Statement is filed with the SEC and mailed to the Record Stockholders.

 

    	 	10	 

     

    

 

(d)          The
Company shall use its commercially reasonable efforts to secure all required authorizations, consents, waivers, amendments and
approvals with respect to the Transactions and the Amendment, including, without limitation, the stockholder approvals described
in Section 5.1(a) and contemplated by the Proxy Statements, including postponing or adjourning the Company Stockholder Meeting
(i) for the absence of a quorum, (ii) to allow reasonable additional time for any supplemental or amended disclosure necessary
under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by the stockholders prior
to the Company Stockholder Meeting or (iv) to allow additional solicitation of votes in order to obtain the Required Shareholder
Approval.

 

(e)          At
the Company Stockholder Meeting, the Purchasers shall vote all of the shares of the Common Stock which they currently beneficially
own, whether directly or indirectly, in favor of the Amendment.

 

4.3         Additional
Listing Application. As promptly as practicable after the date of this Agreement, but in any event after taking into consideration
the rules and regulations of the NYSE MKT with respect to the timing of, and supporting documents required to accompany, the Additional
Listing Application (as hereinafter defined), the Company shall submit to the NYSE MKT an additional listing application relating
to the Securities and the Warrant Shares (the “Additional Listing Application”) and shall use its commercially
reasonable efforts to secure the NYSE MKT’s approval of the Additional Listing Application.

 

4.4         Reservation
of Common Stock. No later than the effective date of the Amendment, the Company will reserve and the Company shall continue
to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose
of enabling the Company to issue the Warrant Shares pursuant to any exercise of the Warrants.

 

4.5         Board
Recommendation. The Board of Directors of the Company shall not withdraw or modify, or propose to or resolve to withdraw or
modify the Board Recommendation, unless a failure to do so would be materially inconsistent with the Board’s fiduciary duties
as determined after consultation with outside legal counsel.

 

Article 5

Conditions Precedent

 

5.1         Conditions
Precedent of the Company. The obligation of the Company to consummate the Transactions shall be subject to the satisfaction
prior to or at the Closing of the following conditions, which may only be waived in writing, in whole or in part, by the Company:

 

(a)          the
Transactions shall have received (i) all requisite approvals of the stockholders of the Company required pursuant to Nevada law,
the Company’s Articles of Incorporation and Bylaws and the rules and regulations of the NYSE MKT (the “Required
Shareholder Approval”) and (ii) approval of a majority of the shares of Common Stock of the Company present in person
or represented by proxy at a meeting of the stockholders of the Company called for such purpose that are not owned, beneficially
or of record, by Elemetal, NTR, or any of their Affiliates (the “Majority of the Minority Requirement”);

 

    	 	11	 

     

    

 

(b)          the
Amendment shall have received all requisite approvals of the stockholders of the Company;

 

(c)          the
representations and warranties of the Purchasers set forth in this Agreement shall have been true and correct in all material respects
as of the date of this Agreement and shall be true and correct in all material respects as of the date of the Closing as if made
on and as of such date;

 

(d)          the
Purchasers shall have performed in all material respects all obligations and complied in all material respects with all covenants
required by this Agreement to be performed or complied with by them at or prior to the Closing (other than a failure to so perform
or comply which is attributable to actions or inactions by or on behalf of the Company); and

 

(e)          the
Purchasers shall have made the deliveries required by Section 1.2(a) hereto.

 

5.2         Conditions
Precedent of the Purchasers. The respective obligations of the Purchasers to consummate the Transactions shall be subject to
the satisfaction prior to or at the Closing of the following conditions, which may only be waived in writing, in whole or in part,
by the Purchasers:

 

(a)          the
Transactions shall have received (i) the Required Shareholder Approval and (ii) the Majority of the Minority Requirement;

 

(b)          the
Amendment shall have received all requisite approvals of the stockholders of the Company;

 

(c)          the
representations and warranties of the Company set forth in this Agreement shall have been true and correct in all material respects
as of the date of this Agreement and shall be true and correct in all material respects as of the date of the Closing as if made
on and as of such date;

 

(d)          the
Company shall have performed in all material respects all obligations and complied in all material respects with all covenants
required by this Agreement to be performed or complied with by it at or prior to the Closing (other than a failure to so perform
or comply which is attributable to actions or inactions by or on behalf of the Purchasers);

 

(e)          the
Company shall have made the deliveries required by Section 1.2(a) hereto;

 

(f)          the Company shall have delivered to the Purchasers a certificate of good standing in respect of the
Company issued by the Secretary of State of the State of Nevada dated as of a date within five calendar days of the Closing;
and

 

(g)          the
Company shall have executed and delivered the Registration Rights Agreement in the form attached as Exhibit B.

  

    	 	12	 

     

    

 

5.3         Conditions
Precedent of the All of the Parties. The respective obligations of each party to consummate the Transactions shall be subject
to the satisfaction prior to or at the Closing of the following conditions, which may only be waived in writing, in whole or in
part, by mutual agreement of the parties:

 

(a)          the
Additional Listing Application shall have been approved by the NYSE MKT; and

 

(b)          no
order or decree of any court or governmental body having competent jurisdiction over the Transactions contemplated by this Agreement
shall prohibit the Transactions.

 

Article 6

Adjustments

 

6.1         Reclassification.
If the Company, at any time prior to the Closing, by reclassification of securities or otherwise, shall change any of the securities
of the same class (the “Comparable Securities”) as the Securities or the Warrant Shares not yet sold, issued
and delivered to, and purchased by, the Purchaser under this Agreement (the “Pending Securities”) into the same
or a different number of securities of any other class or classes, then the Pending Securities shall automatically be adjusted
to be comprised of such number and kind of securities as would have been issuable as a result of such change with respect to the
Comparable Securities immediately prior to such reclassification or other change, and the purchase price for such Pending Securities
shall be proportionately adjusted, if applicable.

 

6.2         Subdivision
or Combination of Shares. If the Company, at any time prior to the Closing, shall split or subdivide the Comparable Securities
into a greater number of securities of the same class, then the number of Pending Securities shall be proportionately increased
and the purchase price to be paid for such Pending Securities shall be proportionately decreased. If the Company, at any time prior
to the Closing, shall reverse split or combine the Comparable Securities into a lesser number of securities of the same class,
then the number of Pending Securities shall be proportionately decreased and the purchase price to be paid for such Pending Securities
shall be proportionately increased.

 

6.3           Certain
Other Matters.

 

(a)          All
calculations under this Article 6 shall be made to the nearest cent or whole Elemetal Share or NTR Share, as the case may
be.

 

(b)          No
adjustment in the Aggregate Consideration shall be required unless such adjustment would require an increase or decrease of at
least U.S.$0.01 per Elemetal Share or NTR Share, as applicable; provided, however, that any adjustments which by reason
of this Section 6.3(b) are not required to be made shall be carried forward and taken into account in any subsequent adjustment.

 

    	 	13	 

     

    

 

(c)          If,
as a result of an adjustment made pursuant to this Article 6, the Company shall be obligated to sell and issue, and the
Purchasers shall be required to purchase, shares of more than one class or series of capital stock of the Company, then the Board
of Directors of the Company (whose determination shall be final and conclusive) shall determine, in good faith, the allocation
of the adjusted Aggregate Consideration between or among the shares of such multiple classes or series of capital stock of the
Company.

 

(d)          If
any event shall occur as to which the other provisions of this Article 6 are not strictly applicable but as to which the
failure to make any adjustment would not fairly preserve the rights and obligations of the Company and the Purchasers under this
Agreement in accordance with the essential intent and principles of the adjustments set forth in this Article 6, then, in
each such case, the Board of Directors of the Company (whose determination shall be final and conclusive) shall determine, in good
faith, the adjustment, if any, on a basis consistent with the essential intent and principles established herein, necessary to
fairly preserve the parties’ respective rights and obligations hereunder.

 

6.4         Certificate
as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Article 6, the Company shall
promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Purchasers a certificate
setting forth, in reasonable detail, the event requiring such adjustment or readjustment, the amount of such adjustment or readjustment,
the method by which such adjustment or readjustment was calculated, the adjusted or readjusted Aggregate Consideration and adjusted
or readjusted number of Pending Securities (including, if requested by Elemetal, a new Warrant reflecting such adjustments).

 

Article 7

Termination

 

7.1         Termination
of this Agreement. This Agreement may be terminated and the Transactions may be abandoned at any time prior to the Closing
as follows: (a) by mutual written consent of the Company and the Purchasers; (b) by either the Company or the Purchasers: (i) after
the Company Stockholder Meeting, if, at the Company Stockholder Meeting, the Transactions do not receive the Required Shareholder
Approval or the Majority of the Minority Approval or the Amendment does not receive all requisite approvals of the Company’s
stockholders or (ii) on or after December 31, 2016, if the Transactions have not been consummated; or (c) by the Purchasers if
(i) the Company fails to include the Board Recommendation in the Proxy Statements or withdraws the Board Recommendation or modifies
the Board Recommendation in a manner adverse thereto or (ii) the Company fails to call the Company Stockholder Meeting or fails
to deliver the Proxy Statements to its stockholders in accordance with this Agreement.

 

7.2           Effect
of Termination. (a) Either party electing to terminate this Agreement pursuant to Section 7.1(b) above may effect such
termination only by promptly delivering written notice thereof to the other party and (b) the Purchasers may terminate this Agreement
pursuant to Section 7.1(c) above by promptly delivering written notice thereof to the Company. Following any termination
duly effected pursuant to Section 7.1, no party shall have any further obligations under this Agreement.

 

    	 	14	 

     

    

 

Article 8

Miscellaneous

 

8.1         Legends.

 

(a)          Each
stock certificate representing the Elemetal Shares and the NTR Shares shall have conspicuously endorsed thereon the following legend:

 

THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY
NOT BE SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

 

(b)          The
Warrant shall be transferrable without the prior written consent of the Company, but shall have conspicuously endorsed thereon
the legend set forth on the first page of the Form of Warrant attached hereto as Exhibit A.

 

(c)          To
the extent the Warrant is exercised, any stock certificate representing the Warrant Shares acquired upon such exercise shall have
conspicuously endorsed thereon the legends set forth in Section 5 of the Form of Warrant attached hereto as Exhibit A.

 

8.2         Brokerage.
Each party will indemnify and hold harmless the other party against and in respect of any claim for brokerage or other commissions
relative to this Agreement or the Transactions, based in any way on agreements, arrangements or understandings made or claimed
to have been made by such party with any third party.

 

8.3         Survival.
Except for the representations and warranties of (a) the Company contained in Sections 2.1, 2.2 and 2.7(a),
and (b) the Purchasers contained in Sections 3.4 and 3.5, which representations and warranties shall survive the Closing,
the respective representations of the Company and Purchasers contained in this Agreement shall not survive the Closing, and thereafter
none of the Company, any Purchaser or any officer, director, employee, or Affiliate of the Company, or any Purchaser shall have
any liability whatsoever (whether pursuant to this Agreement or otherwise) with respect to such representation or warranty. This
Section 8.3 shall have no effect upon any other obligations of the parties hereto under this Agreement, whether to be performed
before, at or after the Closing, which shall survive until fulfilled or the expiration of the time thereof in accordance with their
terms.

 

8.4         Parties
in Interest. All representations, warranties, covenants and agreements contained in this Agreement by or on behalf of either
party shall bind and inure to the benefit of the respective successors and permitted assigns of such party whether so expressed
or not; provided, however, no party may assign, in whole or in part, this Agreement or any right or obligation hereunder,
except as otherwise specified herein, without the prior written consent of the other party.

 

    	 	15	 

     

    

 

8.5         Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly received: (a) on the date
given if delivered personally or by facsimile or electronic transmission; (b) one day after being sent by internationally recognized
overnight delivery service; or (c) five days after having been mailed by registered or certified mail (postage prepaid, return
receipt requested); in the case of each of the foregoing, to the parties at the following addresses (or at such other address for
a party as shall be specified by like notice):

 

	If to the Company:	DGSE Companies, Inc.
	 	15850 Dallas Parkway
	 	Suite 140
	 	Dallas, Texas  75248
	 	Facsimile: (972) 674-2596
	 	Email:mpeakes@dgse.com
	 	Attention: President/ CEO
	 	 
	If to Elemetal:	Elemetal, LLC
	 	15850 Dallas Parkway
	 	Dallas, Texas  75248
	 	Facsimile: (469) 533-1622
	 	Email: bleroy@elemetal.com
	 	Attention: Bill LeRoy, President/CEO
	 	 
	If to NTR:	NTR Metals, LLC
	 	10720 Composite Drive
	 	Dallas, Texas  75220
	 	Facsimile: (469) 522-1100
	 	Email: tgum@elemetal.com
	 	Attention: Carl (Trey) Gum, General Counsel

 

8.6         Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Texas for all purposes and
in all respects, without regard to the conflict of law provisions of such state.

 

8.7         Entire
Agreement. This Agreement constitutes the sole and entire agreement of the parties with respect to the subject matter hereof.

 

8.8         Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.

 

    	 	16	 

     

    

 

8.9         Amendments
and Waivers. This Agreement may be amended or modified in whole or in part at any time only by a writing signed by the parties
hereto. Any term, condition or provision of this Agreement may be waived in writing at any time by the party which is entitled
to the benefits thereof. Any waiver by any party hereto of any of its rights or remedies under this Agreement shall not constitute
a waiver of any of its other rights or remedies hereunder.

 

8.10       Severability.
If any term or provision of this Agreement is finally deemed by a court of competent jurisdiction to be invalid, illegal or incapable
of being enforced, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the Transactions is not affected in any manner materially adverse to any party. Upon such
determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate
in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually
acceptable manner in order that the Transactions be consummated as originally contemplated to the fullest extent possible.

 

8.11       Injunctive
Relief. It is possible that remedies at law may be inadequate and, therefore, the parties shall be entitled to equitable relief,
including, without limitation, injunctive relief, specific performance or other equitable remedies, in addition to all other remedies
provided hereunder or available to the parties at law or in equity.

 

8.12       Titles
and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing
or interpreting any term or provision of this Agreement.

 

[ SIGNATURE PAGE FOLLOWS ]

 

    	 	17	 

     

    

 

IN WITNESS WHEREOF, each of
the parties has caused this Agreement to be duly executed as of the date first above written.

 

	 	THE COMPANY:
	 	 
	 	DGSE Companies, Inc.,
	 	a Nevada corporation
	 	 
	 	By:	/s/ Matthew Peakes
	 	Name:	 Matthew Peakes
	 	Title:	 Chief Executive Officer and President

 

Stock
Purchase Agreement

Signature
Page

 

     

     

    

  

	 	THE PURCHASERS:
	 	 
	 	Elemetal, LLC,
	 	a Delaware limited liability company
	 	 
	 	By:  	/s/ William E. LeRoy
	 	Name:	 William E. LeRoy
	 	Title:	President/CEO
	 	 
	 	NTR Metals, LLC,
	 	a Texas limited liability company
	 	 
	 	By:  	/s/ John Loftus
	 	Name:	 John Loftus
	 	Title:  	Member

  

 

 

Stock
Purchase Agreement

Signature
PageExhibit 10.2

 

FORM OF

WARRANT TO PURCHASE

SHARES OF COMMON STOCK

OF

DGSE COMPANIES, INC.

 

THIS WARRANT AND THE SHARES
(AS HEREINAFTER DEFINED) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE
AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE
STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

 

THIS WARRANT (this “Warrant”)
CERTIFIES THAT, upon the terms and subject to the conditions set forth herein, Elemetal, LLC, a limited liability company organized
and existing under the laws of the State of Delaware (the “Holder”), for good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, has been granted the right to purchase from DGSE Companies, Inc., a Nevada
corporation (the “Company”), during the Term (as hereinafter defined), 1,000,000 shares (the “Shares”)
of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an exercise price of U.S.
$0.65 per Share (the “Exercise Price”) (subject to adjustment hereunder). Until the earlier of the Expiration
Date (as hereinafter defined) and such time as this Warrant is exercised in full, the Exercise Price and the number of Shares (or
consideration) issuable upon exercise of this Warrant are subject to adjustment as hereinafter provided. Capitalized terms used
and not otherwise defined herein shall have the meanings set forth in that certain Stock Purchase Agreement, dated June 20, 2016
(the “Stock Purchase Agreement”), among the Company, the Holder and NTR Metals, LLC, a limited liability company
organized and existing under the laws of the State of Texas.

 

1.          Term.
Upon the terms and subject to the conditions set forth herein, this Warrant shall be exercisable, in whole or in part, at any
time, or from time to time, during the period (such period, the “Term”)
commencing at 5:00 p.m., Eastern time, on ______________, 2016 (the “Effective
Date”) and ending at 5:00 p.m., Eastern time, on _____________,
2018 (the “Expiration Date”).
Any portion of this Warrant remaining unexercised at the Expiration Date shall thereafter be void.

 

2.            Exercise.

 

(a)          Manner
of Exercise. The purchase rights represented by this Warrant are exercisable by the Holder in whole or in part, at any
time, or from time to time, during the Term: (i) by the surrender of this Warrant and the Notice of Exercise (in the form attached
hereto as Exhibit A), duly completed and executed on behalf of the Holder, at the principal executive office of the Company
located at 15850 Dallas Parkway, Suite 140, Dallas, Texas 75248, or such other office as the Company shall notify the Holder of
in writing (the “Principal Office”);
and (ii) upon payment, by wire transfer of immediately available funds to an account designated by the Company of the aggregate
Exercise Price for the Shares to be purchased, or other payment method agreeable to the Company (except that any payment must be
made in accordance with applicable securities laws).

 

     

     

    

 

(b)          Time
of Exercise. This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date
of its surrender for exercise as provided above (the “Exercise
Date”), and the Holder (or other individual or entity
(“Person”)
entitled to receive the Shares issuable upon such exercise in accordance with the terms hereof) shall be treated for all purposes
as the holder of record of such Shares as of the close of business on such date.

 

(c)          Delivery
of Certificate and Balance Warrant. As promptly as practicable on or after the Exercise Date and in any event within three
(3) days thereafter, the Company, at its expense, will issue and deliver to the Holder (or other Person entitled to receive the
Shares issuable upon exercise of this Warrant in accordance with the terms hereof) a certificate or certificates for the Shares
issuable upon such exercise or, if such Shares are not certificated, other appropriate written evidence of the issuance of the
Shares. In the event that this Warrant is exercised in part, the Company at its expense shall execute and deliver to the Holder
(or its successor or permitted assignee) a new warrant of like tenor exercisable for the number of Shares for which this Warrant
may then be exercised after giving effect to all previous exercises and adjustments.

 

(d)          Rescission
Rights. If the Company fails to issue or cause to have issued the Shares issuable upon such exercise of the Warrant within
three (3) days of the Exercise Date, then the Holder will have the right to rescind such exercise.

 

(e)          Charges,
Taxes and Expenses. Issuance of the Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Shares, all of which taxes and expenses shall be paid by the Company,
and such Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder in the Notice
of Exercise. The Company shall pay all fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery
of the Shares.         

 

(f)          No
Fractional Shares. This Warrant my only be exercised for whole Shares, and in no event shall any fractional Share be issued
upon any exercise of this Warrant.

 

(g)          Limitation
on Exercise. Notwithstanding anything to the contrary contained in this Warrant, in no event shall the Holder be entitled
to exercise this Warrant, or to receive Shares issuable upon exercise of this Warrant, for an amount of Shares which, as of the
date of such exercise, is in excess of the number of shares of Common Stock that the Company has sold and issued, and the Holder
has purchased, under the Stock Purchase Agreement, pursuant to which, among other things, this Warrant was issued.

 

    	 	-2-	 

     

    

 

3.            Adjustments.

 

(a)          Reclassification.
If the Company, at any time while this Warrant, or any portion hereof, is outstanding and unexpired, by reclassification of securities
or otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different
number of securities of any other class or classes, then this Warrant shall thereafter represent the right to acquire such number
and kind of securities as would have been issuable as a result of such change with respect to the securities that were subject
to the purchase rights under this Warrant immediately prior to such reclassification or other change, and the Exercise Price shall
be proportionately adjusted, as appropriate.

 

(b)          Subdivision
or Combination of Shares. If the Company, at any time while this Warrant, or any portion hereof, is outstanding and unexpired,
shall split or subdivide the securities for which this Warrant is exercisable into a greater number of securities of the same class,
then the amount of securities for which this Warrant is exercisable shall be proportionately increased and the Exercise Price shall
be proportionately decreased. If the Company, at any time while this Warrant, or any portion hereof, is outstanding and unexpired,
shall reverse split or combine the securities for which this Warrant is exercisable into a lesser number of securities of the same
class, then the amount of securities for which this Warrant is exercisable shall be proportionately decreased and the Exercise
Price shall be proportionately increased.

 

(c)          Adjustments
for Non-Cash Dividends. If, at any time while this Warrant, or any portion thereof, is outstanding and unexpired, the holders
of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record
date fixed for the determination of eligible stockholders, shall have become entitled to receive, without payment therefor, other
or additional securities or property (other than cash) of the Company by way of dividend or distribution (collectively, a “Dividend”),
then, in each case, this Warrant shall represent the right to acquire, in addition to the number of Shares receivable upon exercise
of this Warrant, and without payment of any additional consideration therefor, the amount of such other or additional securities
or property (other than cash) of the Company that the Holder (or its successor or permitted assignee) would hold on the date of
exercise of this Warrant had it been the holder of record of the security receivable upon exercise of this Warrant on the record
date fixed with respect to the Dividend and had thereafter, during the period from the date thereof through and including the date
of such exercise, retained such securities and all other additional securities which it would have received during such period
as a result of its ownership thereof, giving effect to all adjustments called for during such period by the provisions of this
Warrant.

 

    	 	-3-	 

     

    

 

4.            Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental
Transaction”), then, upon any subsequent exercise of
this Warrant, the Holder shall have the right to receive, for each Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder, the number of shares of Common Stock of
the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant
is exercisable immediately prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Upon the occurrence of any such Fundamental Transaction in
which the Company is the survivor (such surviving entity, the “Successor
Entity”), the Successor Entity shall succeed to, and
be substituted for, the Company (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant
and the other documents entered into in connection with the Transactions referring to the “Company”
shall refer instead to the Successor Entity), and the Successor Entity may exercise every right and power of the Company
and shall assume all of the obligations of the Company under this Warrant and the other documents entered into in connection with
the Transactions with the same effect as if such Successor Entity had been named as the Company herein.

 

5.            Certain
Other Matters.

 

(a)          All
calculations under Section 3 and Section 4 shall be made to the nearest cent or whole Share, as the case may be.
For purposes of Section 3 and Section 4, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

    	 	-4-	 

     

    

 

(b)          No
adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least U.S.
$0.01 per Share; provided, however, that any adjustments which by reason of this Section 5(b) are not required to be made
shall be carried forward and taken into account in any subsequent adjustment.

 

(c)          If,
as a result of an adjustment made pursuant to Section 3 or Section 4, the Holder (or its successor or permitted assignee)
shall become entitled to receive shares of more than one class or series of capital stock of the Company, then the Board (whose
determination shall be final and conclusive) shall determine, in good faith, the allocation of the adjusted Exercise Price between
or among the shares of such multiple classes or series of capital stock of the Company.

 

(d)          If
any event shall occur as to which the other provisions of Section 3 or Section 4 are not strictly applicable but
as to which the failure to make any adjustment would not fairly preserve the purchase rights represented by this Warrant in accordance
with the essential intent and principles of the adjustments set forth in Section 3 and Section 4, then, in each such
case, the Board (whose determination shall be final and conclusive) shall determine, in good faith, the adjustment, if any, on
a basis consistent with the essential intent and principles established herein, necessary to fairly preserve the purchase rights
represented by this Warrant.

 

6.            Certificate
as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to Section 3 or Section
4, the Company shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to
the Holder (or its successor or permitted assignee) a certificate setting forth, in reasonable detail, the event requiring
such adjustment or readjustment, the amount of such adjustment or readjustment, the method by which such adjustment or
readjustment was calculated, the adjusted or readjusted Exercise Price and adjusted or readjusted number of Shares or amount
of other securities or property that would be received upon the exercise of this Warrant.

 

7.            Legend.
Each stock certificate representing Shares issued upon exercise of this Warrant shall have conspicuously endorsed thereon the
following legend:

 

THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY
NOT BE SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS.

 

8.            Shares
to be Fully Paid. When issued and delivered in accordance with this Warrant to the Holder (or its successor or permitted
assignee) upon payment to the Company of the applicable Exercise Price, the Shares issued by the Company pursuant to this Warrant
will be fully paid and non-assessable with no personal liability attaching to ownership thereof and will be free and clear of
all liens, charges and encumbrances of any nature whatsoever except for restrictions on transfer under the Stock Purchase Agreement
and under applicable federal and state securities laws.

 

    	 	-5-	 

     

    

 

9.            Company
to Reserve Shares. At all times while this Warrant, or any portion hereof, is outstanding and unexpired, the Company shall
reserve and keep available, free from preemptive rights, out of its authorized but unissued capital stock, for the purpose of
effecting the exercise of this Warrant, the full number of Shares then deliverable upon the exercise of this Warrant. The issuance
of this Warrant shall constitute full authority to those officers of the Company who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates for Shares upon exercise of this Warrant.

 

10.          Exchange
of Warrant. If this Warrant shall be mutilated, lost, stolen or destroyed, then the Company shall execute and deliver
to the Holder (or its successor or permitted assignee) a new warrant of like tenor and denomination and deliver the same (i) in
exchange and substitution for and upon surrender and cancellation of any mutilated Warrant or (ii) in lieu of any Warrant lost,
stolen or destroyed, upon receipt of evidence reasonably satisfactory to the Company of the loss, theft or destruction of such
Warrant (including, without limitation, a reasonably detailed affidavit with respect to the circumstances of any loss, theft or
destruction) and upon receipt of indemnity reasonably satisfactory to the Company.

 

11.          No
Rights as Stockholder. Except as otherwise provided herein, this Warrant, to the extent not exercised, will not entitle
the Holder to any of the rights, including, without limitation, voting rights, information rights and rights to receive dividends
or distributions, of a stockholder of the Company.

 

12.          Amendment.
This Warrant may not be modified or amended, except with the prior written consent of the Holder (or its successor or permitted
assignee) and the Company. Any instrument given by or on behalf of the Holder (or its successor or permitted assignee) in connection
with any consent to any modification or amendment of this Warrant will be conclusive and binding on any and all subsequent holders
of this Warrant.

 

13.          Transfer.
Neither this Warrant nor the Shares have been registered under the Securities Act of 1933, as amended, or any state securities
laws, and such securities may not be offered for sale, sold, assigned, pledged, or otherwise disposed of, unless they are registered
under the Securities Act of 1933, as amended, and such state laws or the transaction is exempt from the registration requirements
thereof. Subject to the foregoing, upon surrender of this Warrant as a result of a transfer hereof, the Company, at the expense
of the Company, will issue and deliver to, or to the order of, the transferee a new Warrant in the name of such transferee, exercisable
for the number of Shares for which this Warrant may then be exercised after giving effect to all previous exercises and adjustments.
Subject to the foregoing, nothing herein shall be construed to limit the number of transfers of the Warrant (including transfers
of fractional interests herein).

 

14.          Successors
and Assigns. This Warrant shall be binding upon the Company and its successors and assigns and shall inure to the benefit
of the Holder and its successors and permitted assigns.

 

    	 	-6-	 

     

    

 

15.          Titles
and Subtitles. The titles and subtitles used in this Warrant are for convenience only and are not to be considered in
construing or interpreting any term or provision of this Warrant.

 

16.          Governing
Law. This Warrant shall be governed by and construed in accordance with the laws of the State of Texas for all purposes
and in all respects, without regard to the conflict of law provisions of such state.

 

[ SIGNATURE PAGE FOLLOWS ]

 

    	 	-7-	 

     

    

 

IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its duly authorized officer as of the Effective Date set forth above.

 

	 	DGSE Companies, Inc.,
	 	a Delaware corporation
	 	 
	 	By:	 
	 	Name: Matthew Peakes
	 	Title: Chief Executive Officer and President

 

Warrant
Signature Page

 

     

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE

 

Dated: ________, 20__

 

The undersigned hereby
elects to purchase ____ shares (the “Shares”) of common stock of DGSE Companies, Inc. (the “Company”)
pursuant to the terms of the warrant issued to the undersigned, effective as of ______________, 2016, a copy of which is attached
hereto (the “Warrant”), and tenders herewith payment to the Company of U.S. $0.65 per Share, for an aggregate
purchase price of U.S. $__________, representing payment in full for the Shares in accordance with the terms of the Warrant. Such
aggregate purchase price is being paid by wire transfer of immediately available funds to an account designated by the Company,
or other payment method agreeable to the Company. Until the earlier of the Expiration Date (as defined in the Warrant) and such
time as the Warrant is exercised in full, the Exercise Price (as defined in the Warrant) and the number of Shares (or consideration)
issuable upon exercise of the Warrant are subject to adjustment as provided in the Warrant.

 

Please issue certificate(s)
representing the Shares, and a new warrant for the unexercised portion of the Warrant [strike if not applicable], in the name of
the undersigned, and deliver such certificate(s) and new warrant [strike if not applicable] to the undersigned at the following
address:

 

Elemetal, LLC

15850 Dallas Parkway

Dallas, Texas 75248

Attn: President/CEO

 

	 	Elemetal, LLC
	 	 
	 	By:	 

	 	Name:	 
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]